CTOs on the Move

Emerging Health Information Technology

www.emerginghealthit.com

 
Emerging Health Information Technology is a Yonkers, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Planned Parenthood

Planned Parenthood Federation of America is a nonprofit organization that provides sexual health care in the United States and globally. They are a trusted health care provider, an informed educator, a passionate advocate, and a global partner helping ...

Crowne Management

Crowne Management is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Monroeville, AL. To find more information about Crowne Management, please visit www.crownemanagement.com

Senior Access

Senior Access is a San Rafael, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vigil Health Solutions

Vigil Health Solutions Inc. is a Victoria, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.